Bangladesh

Bangladesh

Hepatitis B

Download HBV data

Prevalence of chronic HBV (HBsAg+)

National
Download
Value (%) Year Type Source
2.16 (1.97 - 2.35) 2019 Modelled IHME
2.19 (2 - 2.37) 2018 Modelled IHME
2.22 (2.02 - 2.41) 2017 Modelled IHME
2.25 (2.06 - 2.45) 2016 Modelled IHME
2.29 (2.09 - 2.50) 2015 Modelled IHME
2.33 (2.14 - 2.54) 2014 Modelled IHME
2.38 (2.18 - 2.58) 2013 Modelled IHME
2.43 (2.21 - 2.62) 2012 Modelled IHME
2.47 (2.25 - 2.68) 2011 Modelled IHME
2.52 (2.28 - 2.74) 2010 Modelled IHME
2.57 (2.33 - 2.78) 2009 Modelled IHME
2.63 (2.38 - 2.84) 2008 Modelled IHME
2.68 (2.43 - 2.90) 2007 Modelled IHME
2.73 (2.47 - 2.96) 2006 Modelled IHME
2.76 (2.50 - 3.01) 2005 Modelled IHME
2.78 (2.52 - 3.03) 2004 Modelled IHME
2.8 (2.54 - 3.05) 2003 Modelled IHME
2.81 (2.55 - 3.08) 2002 Modelled IHME
2.83 (2.56 - 3.10) 2001 Modelled IHME
2.84 (2.56 - 3.13) 2000 Modelled IHME
2.86 (2.59 - 3.13) 1999 Modelled IHME
2.88 (2.61 - 3.13) 1998 Modelled IHME
2.89 (2.62 - 3.16) 1997 Modelled IHME
2.91 (2.63 - 3.19) 1996 Modelled IHME
2.93 (2.64 - 3.21) 1995 Modelled IHME
2.95 (2.68 - 3.23) 1994 Modelled IHME
2.97 (2.71 - 3.25) 1993 Modelled IHME
3 (2.73 - 3.27) 1992 Modelled IHME
3.03 (2.74 - 3.30) 1991 Modelled IHME
3.06 (2.76 - 3.35) 1990 Modelled IHME
4 (3.22 - 5.02) 2015 Modelled WHO
Showing out of
Show more
Children under-5 years
Download
Value (%) Year Type Source
0.13 (0.10 - 0.16) 2019 Modelled IHME
0.14 (0.11 - 0.17) 2018 Modelled IHME
0.15 (0.12 - 0.18) 2017 Modelled IHME
0.15 (0.12 - 0.19) 2016 Modelled IHME
0.16 (0.12 - 0.19) 2015 Modelled IHME
0.16 (0.13 - 0.20) 2014 Modelled IHME
0.16 (0.13 - 0.20) 2013 Modelled IHME
0.16 (0.13 - 0.20) 2012 Modelled IHME
0.17 (0.14 - 0.21) 2011 Modelled IHME
0.18 (0.14 - 0.22) 2010 Modelled IHME
0.21 (0.17 - 0.26) 2009 Modelled IHME
0.29 (0.23 - 0.36) 2008 Modelled IHME
0.4 (0.32 - 0.50) 2007 Modelled IHME
0.53 (0.41 - 0.66) 2006 Modelled IHME
0.65 (0.51 - 0.81) 2005 Modelled IHME
0.8 (0.63 - 0.99) 2004 Modelled IHME
1 (0.80 - 1.21) 2003 Modelled IHME
1.2 (0.96 - 1.45) 2002 Modelled IHME
1.36 (1.09 - 1.64) 2001 Modelled IHME
1.44 (1.15 - 1.75) 2000 Modelled IHME
1.47 (1.19 - 1.80) 1999 Modelled IHME
1.49 (1.20 - 1.83) 1998 Modelled IHME
1.51 (1.22 - 1.86) 1997 Modelled IHME
1.52 (1.22 - 1.88) 1996 Modelled IHME
1.54 (1.23 - 1.92) 1995 Modelled IHME
1.56 (1.25 - 1.94) 1994 Modelled IHME
1.59 (1.26 - 1.96) 1993 Modelled IHME
1.61 (1.28 - 1.99) 1992 Modelled IHME
1.64 (1.30 - 2.03) 1991 Modelled IHME
1.66 (1.32 - 2.07) 1990 Modelled IHME
1.38 (0.97 - 1.91) 2015 Modelled WHO
Showing out of
Show more

Percent of liver cancer deaths attributable to HBV

National
Download
Value (%) Year Type Source
22 (17 - 29) 2019 Modelled IHME
22 (17 - 29) 2018 Modelled IHME
22 (17 - 29) 2017 Modelled IHME
23 (17 - 30) 2016 Modelled IHME
23 (17 - 30) 2015 Modelled IHME
23 (18 - 31) 2014 Modelled IHME
24 (18 - 31) 2013 Modelled IHME
24 (18 - 32) 2012 Modelled IHME
24 (19 - 32) 2011 Modelled IHME
25 (19 - 32) 2010 Modelled IHME
25 (19 - 32) 2009 Modelled IHME
25 (19 - 33) 2008 Modelled IHME
25 (20 - 33) 2007 Modelled IHME
26 (20 - 33) 2006 Modelled IHME
26 (20 - 34) 2005 Modelled IHME
27 (21 - 34) 2004 Modelled IHME
27 (21 - 35) 2003 Modelled IHME
28 (22 - 35) 2002 Modelled IHME
29 (23 - 36) 2001 Modelled IHME
29 (23 - 37) 2000 Modelled IHME
30 (24 - 37) 1999 Modelled IHME
30 (24 - 37) 1998 Modelled IHME
30 (24 - 38) 1997 Modelled IHME
31 (25 - 38) 1996 Modelled IHME
31 (24 - 38) 1995 Modelled IHME
30 (24 - 38) 1994 Modelled IHME
30 (24 - 37) 1993 Modelled IHME
30 (24 - 37) 1992 Modelled IHME
30 (24 - 37) 1991 Modelled IHME
30 (24 - 38) 1990 Modelled IHME
Showing out of
Show more
Technical notes

Coverage of 3-dose hepatitis B vaccine

Infants
Download
Value (%) Year Type Source
98 2018 Survey/reported WHO/UNICEF
98 2017 Survey/reported WHO/UNICEF
98 2016 Survey/reported WHO/UNICEF
98 2015 Survey/reported WHO/UNICEF
97 2014 Survey/reported WHO/UNICEF
96 2013 Survey/reported WHO/UNICEF
94 2012 Survey/reported WHO/UNICEF
96 2011 Survey/reported WHO/UNICEF
94 2010 Survey/reported WHO/UNICEF
97 2009 Survey/reported WHO/UNICEF
96 2008 Survey/reported WHO/UNICEF
95 2007 Survey/reported WHO/UNICEF
86 2006 Survey/reported WHO/UNICEF
45 2005 Survey/reported WHO/UNICEF
11 2004 Survey/reported WHO/UNICEF
5 2003 Survey/reported WHO/UNICEF
Showing out of
Show more
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Hepatitis C

Download HCV data

Prevalence of chronic HCV (RNA+/cAg)

National
Download
Value (%) Year Type Source
0.53 (0.43 - 0.65) 2019 Modelled IHME
0.53 (0.43 - 0.65) 2018 Modelled IHME
0.53 (0.43 - 0.65) 2017 Modelled IHME
0.53 (0.43 - 0.64) 2016 Modelled IHME
0.53 (0.43 - 0.65) 2015 Modelled IHME
0.51 (0.42 - 0.63) 2014 Modelled IHME
0.48 (0.39 - 0.58) 2013 Modelled IHME
0.44 (0.36 - 0.53) 2012 Modelled IHME
0.41 (0.33 - 0.49) 2011 Modelled IHME
0.39 (0.32 - 0.48) 2010 Modelled IHME
0.4 (0.33 - 0.49) 2009 Modelled IHME
0.42 (0.35 - 0.51) 2008 Modelled IHME
0.45 (0.37 - 0.53) 2007 Modelled IHME
0.47 (0.39 - 0.56) 2006 Modelled IHME
0.48 (0.40 - 0.58) 2005 Modelled IHME
0.49 (0.41 - 0.59) 2004 Modelled IHME
0.49 (0.41 - 0.59) 2003 Modelled IHME
0.5 (0.41 - 0.59) 2002 Modelled IHME
0.5 (0.42 - 0.60) 2001 Modelled IHME
0.51 (0.42 - 0.61) 2000 Modelled IHME
0.53 (0.43 - 0.63) 1999 Modelled IHME
0.56 (0.46 - 0.67) 1998 Modelled IHME
0.6 (0.48 - 0.72) 1997 Modelled IHME
0.63 (0.51 - 0.77) 1996 Modelled IHME
0.65 (0.53 - 0.81) 1995 Modelled IHME
0.67 (0.54 - 0.82) 1994 Modelled IHME
0.68 (0.54 - 0.83) 1993 Modelled IHME
0.68 (0.55 - 0.84) 1992 Modelled IHME
0.69 (0.56 - 0.85) 1991 Modelled IHME
0.69 (0.56 - 0.85) 1990 Modelled IHME
Showing out of
Show more

Prevalence of anti-HCV

National
Download
Value (%) Year Type Source
1.3 (0.20 - 2.20) 2014 Modelled Gower et al, 2014
People who inject drugs (PWID)
Download
Value (%) Year Type Source
33.9 (22.40 - 45.40) 2013 Modelled Degenhardt L et al, 2017

Percent of liver cancer deaths attributable to HCV

National
Download
Value (%) Year Type Source
43 (33 - 51) 2019 Modelled IHME
42 (33 - 51) 2018 Modelled IHME
42 (33 - 51) 2017 Modelled IHME
42 (32 - 50) 2016 Modelled IHME
41 (32 - 50) 2015 Modelled IHME
41 (32 - 49) 2014 Modelled IHME
41 (31 - 49) 2013 Modelled IHME
40 (31 - 49) 2012 Modelled IHME
40 (31 - 48) 2011 Modelled IHME
40 (30 - 48) 2010 Modelled IHME
39 (30 - 48) 2009 Modelled IHME
39 (30 - 47) 2008 Modelled IHME
38 (29 - 47) 2007 Modelled IHME
38 (29 - 46) 2006 Modelled IHME
37 (29 - 46) 2005 Modelled IHME
37 (28 - 45) 2004 Modelled IHME
36 (28 - 44) 2003 Modelled IHME
35 (27 - 43) 2002 Modelled IHME
34 (26 - 42) 2001 Modelled IHME
33 (26 - 41) 2000 Modelled IHME
33 (26 - 40) 1999 Modelled IHME
32 (25 - 40) 1998 Modelled IHME
32 (24 - 39) 1997 Modelled IHME
31 (24 - 39) 1996 Modelled IHME
31 (24 - 39) 1995 Modelled IHME
31 (24 - 39) 1994 Modelled IHME
32 (24 - 39) 1993 Modelled IHME
32 (24 - 39) 1992 Modelled IHME
32 (25 - 39) 1991 Modelled IHME
32 (25 - 39) 1990 Modelled IHME
Showing out of
Show more
Technical notes
HBV National Action Plan
HBV elimination goal
HepB birth dose policy
No
Eligible for HBV generic medicines
HCV National Action Plan
HCV elimination goal
HCV testing policy
No
Eligible for HCV generic medicines
At least one needle-syringe exchange program (NSP) operational
Yes
At least one opioid substitution therapy (OST) program operational
Yes
NSP in at least one prison
No
OST in at least one prison
No

Overview

HBV elimination goal
HCV elimination goal

Prevalence (national)

Modelled

HBV (HBsAg+)
2.16 (%)
2019
(1.97 - 2.35(%))
IHME
HCV (RNA/cAg+)
0.53 (%)
2019
(0.43 - 0.65(%))
IHME

Survey/surveillance

No data available
No data available

Hepatitis related deaths (national)

Modelled

HBV
8,693
2019
(6,074 - 12,146)
IHME

Survey/surveillance

No data available
HBV chart

Modelled

HCV
8,296
2019
(6,016 - 11,115)
IHME

Survey/surveillance

No data available
HCV chart

Prevalence < 5

HBV
0.13 (%)
2019, latest modelled
(0.10 - 0.16(%))
IHME

Prevalence PWID

HCV
33.90 (%)
2013, latest modelled
(22.40 - 45.40(%))
Degenhardt L et al, 2017

Birth dose vaccination coverage (national)

Survey/surveillance

No data available

No. of syringes/PWID/year

Survey/surveillance

No data available
Eligible for HBV generic medicines
Eligible for HCV generic medicines